Lexpos News

The mid-term election for an ‘Independent regional representative’ for Community Pharmacy England’s East and North Midlands region begins next week. This follows Lindsey Fairbrother’s resignation from the Committee. Eligible pharmacists* who are Independent pharmacy owners and members or officers of one of the LPCs in the region are invited to stand for election as the [...]

The post Process announced for CPE East and North Midlands Regional Representative election appeared first on Community Pharmacy England.

Community Pharmacy England met in London for a full Committee meeting on 22nd and 23rd April. Despite significant efforts by all parties, negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2026/27 have not yet concluded. Government requirements dictate that negotiations must remain confidential but, as pharmacy owners themselves, Committee Members know [...]

The post Latest 2026/27 CPCF negotiations position scrutinised at April meeting appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Budesonide 3mg gastro-resistant modified-release capsules Tillotts Pharma UK Ltd 100 capsules Complete pack Deferiprone [...]

The post 6 products re-classified as special containers from May 2026 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/04/2026) confirmed the following list of price concessions for April 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post April 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/22 Date issued: 28 April 2026 Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site. DMRC reference number: DMRC-39135670 Company name: Amarox Limited Medicine Details Sertraline 100mg [...]

The post MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) appeared first on Community Pharmacy England.